Are you curious about where tocilizumab is made in India? Understanding the top manufacturers can help you make informed choices for your health. By comparing these factories, you’ll discover quality, reliability, and innovation. Dive in to find out which options stand out and why it matters!
Tocilizumab Injection IP – India Business Directory
Product Details: Tocilizumab Injection IP
Technical Parameters:
– Strength: 400 mg, 200 mg, 80 mg
– Packaging Type: Vial
Application Scenarios:
– Rheumatoid Arthritis
– COVID – 19
Pros:
– Effective in treating inflammatory conditions
– Available in multiple strengths
Cons:
– Requires a valid prescription
– Potential side effects may occur
Tocilizumab Injection Manufacturers in India – PharmaAdda
Product Details: Tocilizumab Injection, 400mg/20ml, used for the treatment of COVID-19 and other inflammatory conditions.
Technical Parameters:
– Packaging Size: 20ml
– Composition: Tocilizumab 400mg
Application Scenarios:
– Treatment of COVID-19 in hospitalized patients requiring supplemental oxygen.
– Management of rheumatoid arthritis and other inflammatory conditions.
Pros:
– High-quality manufacturing by leading pharmaceutical companies.
– Emergency Use Authorization by FDA for COVID-19 treatment.
Cons:
– Requires prescription for use.
– Potential side effects associated with biological medicines.
Tocilizumab Injection Manufacturers in India – India Business Directory
Product Details: Tocilizumab Injection is used to treat various inflammatory conditions of the joints, including rheumatoid arthritis and juvenile idiopathic arthritis. It is available in strengths of 400 mg and is packaged in vials of 20 ml.
Technical Parameters:
– Strength: 400 mg
– Packaging Type: Vial, Packaging Size: 20 ml
Application Scenarios:
– Rheumatoid arthritis
– Juvenile idiopathic arthritis
Pros:
– Effective in treating inflammatory conditions
– Available from multiple manufacturers
Cons:
– Requires a valid prescription
– Potential side effects may occur
Hetero gets approval to make Roche’s tocilizumab in India under the …
Product Details: Tocira is a generic version of tocilizumab produced by Hetero in India, approved for emergency use to treat Covid-19.
Technical Parameters:
– Humanized monoclonal antibody
– Inhibits interleukin-6 receptor
Application Scenarios:
– Treatment for hospitalized adults with Covid-19
– Patients requiring invasive/non-invasive mechanical ventilation or supplementary…
Pros:
– Reduces recovery time for Covid-19 patients
– Lowers mortality risk in hospitalized patients
Cons:
– Facing shortages due to high demand during Covid-19 spikes
– Limited to emergency use approval
Tocira – Tocilizumab, Tocilizumab Injection Manufacturer and Bulk …
Product Details: Tocira 400 mg Injection (Tocilizumab) is indicated for restricted use under emergency situations to treat hospitalized adults with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive, or invasive mechanical ventilation.
Technical Parameters:
– Each vial contains 400 mg of Tocilizumab in 20 ml.
– Shelf life is 12 months.
Application Scenarios:
– Treatment of COVID-19 in hospitalized adults.
– Emergency use for patients requiring supplemental oxygen or mechanical ventilati…
Pros:
– Recombinant humanized monoclonal antibody targeting interleukin 6 receptor.
– Single intravenous injection administered over 60 minutes.
Cons:
– Subcutaneous administration is restricted for COVID-19 treatment.
– May require additional infusion if symptoms worsen after the first dose.
Tocilizumab Injection – Alleviare Life Sciences
Product Details: Tocilizumab Injection is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, and to slow a decrease in lung function for patients with systemic sclerosis-related lung disease.
Technical Parameters:
– Active substance: Tocilizumab Injection
– Strength: 80mg / 200mg / 400mg
Application Scenarios:
– Treatment of rheumatoid arthritis
– Management of cytokine release syndrome
Pros:
– Effective in treating multiple autoimmune conditions
– Available in various strengths for tailored treatment
Cons:
– Potential side effects associated with immunosuppressive therapy
– Requires prescription and medical supervision
Hetero Biopharma
Product Details: Hetero’s biosimilar version of Tocilizumab, marketed as Tocira, received Emergency Use Authorization (EUA) from DCGI for the treatment of Covid-19 in hospitalized adults.
Technical Parameters:
– Biosimilar version of Roche’s Actemra/RoActemra
– Available in 400mg/20ml dosage
Application Scenarios:
– Treatment of Covid-19 in hospitalized adults
– Used in patients receiving systemic corticosteroids and requiring supplemental o…
Pros:
– Addresses global shortage of Tocilizumab
– Manufactured at a dedicated biologics facility in India
Cons:
– Restricted use under Emergency Use Authorization
– Limited to specific patient conditions
Tocilizumab Injection Manufacturers, Suppliers, Dealers & Prices
Product Details: Tocilizumab Injection is a biologic drug used primarily for the treatment of autoimmune diseases such as rheumatoid arthritis and giant cell arteritis. It is administered via injection and is available in various dosages including 80 mg, 200 mg, and 400 mg.
Technical Parameters:
– Salt Composition: Tocilizumab (recombinant humanized anti-IL-6 receptor monoclon…
– Physical Form: Liquid Injection
Application Scenarios:
– Treatment of rheumatoid arthritis and juvenile idiopathic arthritis
– Management of cytokine release syndrome in severe COVID-19 cases
Pros:
– Effective in reducing inflammation and managing autoimmune conditions
– Administered by healthcare professionals ensuring proper usage
Cons:
– Requires prescription and supervision by healthcare professionals
– Potential side effects and contraindications may limit use in some patients
Roche Pharma India partners with Cipla to create greater access to key …
Product Details: Tocilizumab (Actemra) and Bevacizumab (Syndyma) are innovative medicines used for treating various medical conditions including cancer and rheumatoid arthritis.
Technical Parameters:
– Tocilizumab: Recombinant humanized anti IL-6 receptor monoclonal antibody.
– Bevacizumab: Recombinant humanized monoclonal antibody that binds to VEGF.
Application Scenarios:
– Treatment of rheumatoid arthritis and related conditions.
– Treatment of various types of cancers including brain, kidney, lung, colon, rect…
Pros:
– Improves access to critical medicines for patients in India.
– Backed by clinical trials proving efficacy and safety.
Cons:
– Potential side effects associated with monoclonal antibody therapies.
– Limited access for patients who may not be covered by healthcare plans.
Enzene and Hetero Gain DCGI Approvals for Denosumab, Tocilizumab Products
Product Details: Denosumab biosimilar by Enzene and Tocilizumab product by Hetero, both approved by DCGI.
Technical Parameters:
– Denosumab for osteoporosis treatment
– Tocilizumab for COVID-19 treatment
Application Scenarios:
– Treatment of osteoporosis in adults
– Emergency use for hospitalized adults with COVID-19
Pros:
– Potential to address drug shortages
– Cost-effective alternatives to originator biologics
Cons:
– Less rigorous approval standards in India compared to the US and EU
– Need for extensive trials for global commercialization
Related Video
Comparison Table
| Company | Product Details | Pros | Cons | Website |
|---|---|---|---|---|
| Tocilizumab Injection IP – India Business Directory | Tocilizumab Injection IP | – Effective in treating inflammatory conditions – Available in multiple strengths | – Requires a valid prescription – Potential side effects may occur | dir.indiamart.com |
| Tocilizumab Injection Manufacturers in India – PharmaAdda | Tocilizumab Injection, 400mg/20ml, used for the treatment of COVID-19 and other inflammatory conditions. | – High-quality manufacturing by leading pharmaceutical companies. – Emergency Use Authorization by FDA for COVID-19 treatment. | – Requires prescription for use. – Potential side effects associated with biological medicines. | www.pharmaadda.in |
| Tocilizumab Injection Manufacturers in India – India Business Directory | Tocilizumab Injection is used to treat various inflammatory conditions of the joints, including rheumatoid arthritis and juvenile idiopathic arthritis… | – Effective in treating inflammatory conditions – Available from multiple manufacturers | – Requires a valid prescription – Potential side effects may occur | dir.indiamart.com |
| Hetero gets approval to make Roche’s tocilizumab in India under the … | Tocira is a generic version of tocilizumab produced by Hetero in India, approved for emergency use to treat Covid-19. | – Reduces recovery time for Covid-19 patients – Lowers mortality risk in hospitalized patients | – Facing shortages due to high demand during Covid-19 spikes – Limited to emergency use approval | lifescivoice.com |
| Tocira – Tocilizumab, Tocilizumab Injection Manufacturer and Bulk … | Tocira 400 mg Injection (Tocilizumab) is indicated for restricted use under emergency situations to treat hospitalized adults with COVID-19 who are re… | – Recombinant humanized monoclonal antibody targeting interleukin 6 receptor. – Single intravenous injection administered over 60 minutes. | – Subcutaneous administration is restricted for COVID-19 treatment. – May require additional infusion if symptoms worsen after the first dose. | www.heterohealthcare.com |
| Tocilizumab Injection – Alleviare Life Sciences | Tocilizumab Injection is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, and to sl… | – Effective in treating multiple autoimmune conditions – Available in various strengths for tailored treatment | – Potential side effects associated with immunosuppressive therapy – Requires prescription and medical supervision | medex.alleviareindia.com |
| Hetero Biopharma | Hetero’s biosimilar version of Tocilizumab, marketed as Tocira, received Emergency Use Authorization (EUA) from DCGI for the treatment of Covid-19 in… | – Addresses global shortage of Tocilizumab – Manufactured at a dedicated biologics facility in India | – Restricted use under Emergency Use Authorization – Limited to specific patient conditions | heterobiopharma.com |
| Tocilizumab Injection Manufacturers, Suppliers, Dealers & Prices | Tocilizumab Injection is a biologic drug used primarily for the treatment of autoimmune diseases such as rheumatoid arthritis and giant cell arteritis… | – Effective in reducing inflammation and managing autoimmune conditions – Administered by healthcare professionals ensuring proper usage | – Requires prescription and supervision by healthcare professionals – Potential side effects and contraindications may limit use in some patients | www.tradeindia.com |
| Roche Pharma India partners with Cipla to create greater access to key … | Tocilizumab (Actemra) and Bevacizumab (Syndyma) are innovative medicines used for treating various medical conditions including cancer and rheumatoid… | – Improves access to critical medicines for patients in India. – Backed by clinical trials proving efficacy and safety. | – Potential side effects associated with monoclonal antibody therapies. – Limited access for patients who may not be covered by healthcare plans. | www.rocheindia.com |
| Enzene and Hetero Gain DCGI Approvals for Denosumab, Tocilizumab Products | Denosumab biosimilar by Enzene and Tocilizumab product by Hetero, both approved by DCGI. | – Potential to address drug shortages – Cost-effective alternatives to originator biologics | – Less rigorous approval standards in India compared to the US and EU – Need for extensive trials for global commercialization | www.centerforbiosimilars.com |
Frequently Asked Questions (FAQs)
What is tocilizumab, and what is it used for?
Tocilizumab is a monoclonal antibody that targets the interleukin-6 (IL-6) receptor. It’s primarily used to treat autoimmune conditions like rheumatoid arthritis and is also used in managing severe cases of COVID-19. Its role is to help reduce inflammation and modulate the immune response.
Which companies manufacture tocilizumab in India?
Several companies manufacture tocilizumab in India, including major pharmaceutical firms like Roche and its Indian subsidiary, as well as other local manufacturers. These companies ensure that the drug is available to patients in need across the country.
Are the manufacturing facilities in India compliant with international standards?
Yes, most manufacturing facilities in India adhere to stringent international quality standards such as GMP (Good Manufacturing Practices) and are often inspected by global regulatory bodies. This ensures that the tocilizumab produced is safe and effective for use.
How can I find tocilizumab produced in India?
You can find tocilizumab at local pharmacies or hospitals. It’s important to consult with your healthcare provider for a prescription and guidance on where to obtain the medication, ensuring you receive a legitimate product.
Is tocilizumab affordable in India?
Tocilizumab is generally more affordable in India compared to many Western countries, thanks to local manufacturing and government regulations. However, prices may vary based on the manufacturer and the healthcare facility, so it’s best to check with your provider for specific costs.